4503 Jp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Japanese drugmaker Astellas Pharma Inc. has agreed to acquire Iveric Bio Inc., which develops drugs to treat age-related blindness, for about $5.9 billion.

Iveric bioNaoki okamuraIveric bio incAstellas pharma incAstellas pharma4503 jp